OptiBiotix Health plc (OPTI) Ord 2p
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
OptiBiotix to launch new range with India partner
3 December 2024 13:49
(Sharecast News) - OptiBiotix Health announced the upcoming launch of 'SlimBiome'-containing products in India under Dr Morepen's new 'LightLife' brand on Tuesday.
-
OptiBiotix reports 21pc decline in first-half revenue
27 September 2024 12:43
(Sharecast News) - OptiBiotix Health reported a 21.3% decline in revenue to £0.28m for the six months ended 30 June on Friday, compared to £0.35m in the same period last year.
-
OptiBiotix reports solid first-half operational progress
20 August 2024 11:47
(Sharecast News) - Obesity-focussed life science company OptiBiotix Health updated the market on its commercial activities for the first half on Tuesday, reported significant advancements in expanding its...
-
OptiBiotix Health inks manufacturing deal with KAG Industries
30 April 2024 16:55
(Sharecast News) - Life sciences company OptiBiotix Health announced on Tuesday that its its Indian subsidiary, OptiBiotix Health India (OHI), has entered into a manufacturing agreement with KAG Industries...
-
OptiBiotix signs partnership with India's Dr Morepen
13 March 2024 14:28
(Sharecast News) - Life science company OptiBiotix Health announced the signing of a partnership agreement with Dr Morepen on Wednesday, for the distribution of SlimBiome products in India under the Dr...
-
OptiBiotix to launch LeanBiome with Muscletech
15 January 2024 11:34
(Sharecast News) - OptiBiotix Health announced the upcoming launch of LeanBiome in partnership with prominent sports nutrition brand Muscletech on Monday.
-
OptiBiotix makes strong progress in e-commerce shift
1 November 2023 12:58
(Sharecast News) - OptiBiotix Health reported significant progress in its commercial endeavours in an update on Wednesday, as it looked to attain profitability at the business unit level, ultimately leading...
-
OptiBiotix inks ingredient deal with Tata Chemicals
23 October 2023 08:16
(Sharecast News) - Life sciences developer OptiBiotix Health announced a significant agreement with Tata Chemicals on Monday, that would see its proprietary 'Fossence' product incorporated into...
-
OptiBiotix Health reports 'strong' progress in first half
27 September 2023 11:03
(Sharecast News) - Life sciences company OptiBiotix Health reported a "strong" first half of trading on Wednesday, as sales revenue soared 195% to £0.35m.
-
OptiBiotix to launch three brands with Boots
22 September 2023 15:38
(Sharecast News) - Life sciences company OptiBiotix Health announced a collaboration with major pharmacy and health retail chain Boots on Friday.
-
OptiBiotix reports solid progress across product lines
29 August 2023 14:06
(Sharecast News) - OptiBiotix Health announced a number of commercial advancements in an update on Tuesday, disclosing its highest-ever brand-specific online sales levels in July.
-
OptiBiotix launching new product in deal with Shandong Longlive
26 September 2022 14:18
(Sharecast News) - Life science company OptiBiotix Health has signed an exclusive distribution agreement with Shandong Longlive Biotechnology, it announced on Monday, for the distribution of Longlive's...
Company announcements Announcements
-
Holding(s) in Company
12 December 2024 14:45
OptiBiotix Health
-
Launch of Dr Morepen LightLife in India
3 December 2024 07:00
OptiBiotix Health
-
Requisition update
30 October 2024 07:00
OptiBiotix Health
-
Holding(s) in Company
25 October 2024 16:29
OptiBiotix Health
-
Total Voting Rights
24 October 2024 07:00
OptiBiotix Health
-
Directorate Change
23 October 2024 07:00
OptiBiotix Health
-
Response to Publication of Circular by ProBiotix
18 October 2024 07:00
OptiBiotix Health
-
SlimBiome study update
10 October 2024 07:00
OptiBiotix Health
-
Half-year Report
27 September 2024 07:00
OptiBiotix Health
-
Response to Probiotix Health requisition notice
26 September 2024 07:00
OptiBiotix Health
-
ProBiotix Health plc Fundraise
5 September 2024 10:32
OptiBiotix Health
-
Commercial update
20 August 2024 07:00
OptiBiotix Health
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.